Multiple myeloma macrophages: Pivotal players in the tumor microenvironment

Journal of Oncology

Volumn , Issue , 2013, Pages

  Berardi, Simona ^a   Ria, Roberto ^a   Reale, Antonia ^a   De Luisi, Annunziata ^a   Catacchio, Ivana ^a   Moschetta, Michele ^a   Vacca, Angelo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; BORTEZOMIB; CD14 ANTIGEN; CD68 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PROTEINASE; SCATTER FACTOR; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; ZOLEDRONIC ACID;

ANGIOGENESIS; BONE MARROW; CANCER PATIENT; CANCER RESISTANCE; CANCER SURVIVAL; CELL ACTIVATION; CELL FUNCTION; CELL GROWTH; CELL POLARITY; CELL SURVIVAL; HUMAN; IMMUNOMODULATION; MACROPHAGE; MESENCHYMAL STROMA CELL; MOLECULAR MECHANICS; MONOCYTE; MULTIPLE MYELOMA; PLASMA CELL; PROTEIN FUNCTION; REVIEW; STEM CELL NICHE; TUMOR CELL; TUMOR GROWTH; TUMOR MICROENVIRONMENT;

EID: 84874626195     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2013/183602     Document Type: Review

References (40)

1. Kastrinakis N. G., Gorgoulis V. G., Foukas P. G., Dimopoulos M. A., Kittas C., Molecular aspects of multiple myeloma. Annals of Oncology 2000 11 10 1217 1228 2-s2.0-0033758812 10.1023/A:1008331714186
2. Bissell M. J., Hines W. C., Why don't we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nature Medicine 2011 17 3 320 329 2-s2.0-79952392467 10.1038/nm.2328
3. Dalton W. S., Hazlehurst L., Shain K., Landowski T., Alsina M., Targeting the bone marrow microenvironment in hematologic malignancies. Seminars in Hematology 2004 41 2, supplement 4 1 5 2-s2.0-2442533725 (Pubitemid 38649812)
4. Kyle R. A., Rajkumar S. V., Multiple myeloma. The New England Journal of Medicine 2004 351 18 1860 1873
5. Dalton W. S., The tumor microenvironment: focus on myeloma. Cancer Treatment Reviews 2003 29, supplement 1 11 19 (Pubitemid 36626288)
6. Coussens L. M., Werb Z., Inflammation and cancer. Nature 2002 420 6917 860 867 2-s2.0-0037180757 10.1038/nature01322 (Pubitemid 36019639)
7. Pollard J. W., Tumour-educated macrophages promote tumour progression and metastasis. Nature Reviews Cancer 2004 4 1 71 78 2-s2.0-0347123433 (Pubitemid 38082155)
8. Scavelli C., Nico B., Cirulli T., Ria R., Di Pietro G., Mangieri D., Bacigalupo A., Mangialardi G., Coluccia A. M. L., Caravita T., Molica S., Ribatti D., Dammacco F., Vacca A., Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene 2008 27 5 663 674 2-s2.0-38549141574 10.1038/sj.onc.1210691 (Pubitemid 351158901)
9. Gendron R. L., Tsai F. Y., Paradis H., Arceci R. J., Induction of embryonic vasculogenesis by bFGF and LIF in vitro and in vivo. Developmental Biology 1996 177 1 332 346 2-s2.0-0030578402 10.1006/dbio.1996.0167 (Pubitemid 26252503)
10. Martinez F. O., Helming L., Gordon S., Alternative activation of macrophages: an immunologic functional perspective. Annual Review of Immunology 2009 27 451 483 2-s2.0-67650485985 10.1146/annurev.immunol.021908.132532
11. Mantovani A., Sica A., Locati M., New vistas on macrophage differentiation and activation. European Journal of Immunology 2007 37 1 14 16 2-s2.0-33846352854 10.1002/eji.200636910 (Pubitemid 46128780)
12. Mantovani A., Sica A., Sozzani S., Allavena P., Vecchi A., Locati M., The chemokine system in diverse forms of macrophage activation and polarization. Trends in Immunology 2004 25 12 677 686 2-s2.0-7644231561 10.1016/j.it.2004.09. 015 (Pubitemid 39457982)
13. Condeelis J., Pollard J. W., Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006 124 2 263 266 2-s2.0-31044433663 10.1016/j.cell.2006.01.007 (Pubitemid 43121975)
14. Mantovani A., Allavena P., Sica A., Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression. European Journal of Cancer 2004 40 11 1660 1667 2-s2.0-3142644996 10.1016/j.ejca.2004.03.016 (Pubitemid 38902900)
15. Mills C. D., Kincaid K., Alt J. M., Heilman M. J., Hill A. M., M-1/M-2 macrophages and the Th1/Th2 paradigm. Journal of Immunology 2000 164 12 6166 6173 2-s2.0-0034659784 (Pubitemid 30408793)
16. Ribatti D., Nico B., Vacca A., Importance of the bone marrow microenvironment in inducing the angiogenic response in multiple myeloma. Oncogene 2006 25 31 4257 4266 2-s2.0-33746257305 10.1038/sj.onc.1209456 (Pubitemid 44100496)
17. Jenkins D. C., Charles I. G., Thomsen L. L., Roles of nitric oxide in tumor growth. Proceedings of the National Academy of Sciences of the United States of America 1995 92 10 4392 4396
18. Vacca A., Ribatti D., Presta M., Minischetti M., Iurlaro M., Ria R., Albini A., Bussolino F., Dammacco F., Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999 93 9 3064 3073 2-s2.0-0033134764 (Pubitemid 29200799)
19. Di Raimondo F., Azzaro M. P., Palumbo G. A., Bagnato S., Giustolisi G., Floridia P. M., Sortino G., Giustolisi R., Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood. Haematologica 2000 85 8 800 805 2-s2.0-0033835945
20. Zheng Y., Cai Z., Wang S., Zhang X., Qian J., Hong S., Li H., Wang M., Yang J., Yi Q., Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis. Blood 2009 114 17 3625 3628 2-s2.0-70449477633 10.1182/blood-2009-05- 220285
21. Kim J., Denu R. A., Dollar B. A., Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells. British Journal of Haematology 2012 158 3 336 346
22. Gu Z. J., Costes V., Lu Z. Y., Interleukin-10 is a growth factor for human myeloma cells by induction of an oncostatin M autocrine loop. Blood 1996 88 10 3972 3986 (Pubitemid 26383122)
23. Li S., Zhang X., Xia X., Regression of tumor growth and induction of long-term antitumor memory by interleukin 12 electro-gene therapy. Journal of the National Cancer Institute 2002 94 10 762 768 2-s2.0-0037094278 (Pubitemid 34567961)
24. Roccaro A. M., Hideshima T., Raje N., Kumar S., Ishitsuka K., Yasui H., Shiraishi N., Ribatti D., Nico B., Vacca A., Dammacco F., Richardson P. G., Anderson K. C., Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells. Cancer Research 2006 66 1 184 191 2-s2.0-31544433927 10.1158/0008-5472.CAN-05-1195 (Pubitemid 43166024)
25. Mayer H., Bertram H., Lindenmaier W., Korff T., Weber H., Weich H., Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. Journal of Cellular Biochemistry 2005 95 4 827 839 2-s2.0-24744458412 10.1002/jcb.20462 (Pubitemid 41420169)
26. Laurila J. P., Laatikainen L., Castellone M. D., Trivedi P., Heikkila J., Hinkkanen A., Hematti P., Laukkanen M. O., Human embryonic stem cell-derived mesenchymal stromal cell transplantation in a rat hind limb injury model. Cytotherapy 2009 11 6 726 737 2-s2.0-73649115624 10.3109/14653240903067299
27. Vacca A., Ria R., Semeraro F., Endothelial cells in the bone marrow of patients with multiple myeloma. Blood 2003 102 9 3340 3348 (Pubitemid 37314776)
28. Anghelina M., Moldovan L., Zabuawala T., Ostrowski M. C., Moldovan N. I., A subpopulation of peritoneal macrophages form capillary-like lumens and branching patterns in vitro. Journal of Cellular and Molecular Medicine 2006 10 3 708 715 2-s2.0-33845312332 10.2755/jcmm010.003.21 (Pubitemid 44874279)
29. Kumar S., Witzig T. E., Timm M., Haug J., Wellik L., Kimlinger T. K., Greipp P. R., Rajkumar S. V., Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression. Blood 2004 104 4 1159 1165 2-s2.0-3843051264 10.1182/blood-2003-11-3811 (Pubitemid 39038038)
30. Moldovan N. I., Functional adaptation: the key to plasticity of cardiovascular "stem" cells? Stem Cells and Development 2005 14 2 111 121 2-s2.0-18744378576 10.1089/scd.2005.14.111 (Pubitemid 40677384)
31. Barleon B., Sozzani S., Zhou D., Weich H. A., Mantovani A., Marmé D., Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 1996 87 8 3336 3343 2-s2.0-0029867554 (Pubitemid 26115364)
32. Fong G. H., Rossant J., Gertsenstein M., Breitman M. L., Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995 376 6535 66 70 2-s2.0-0029021660
33. Shalaby F., Ho J., Stanford W. L., Fischer K. D., Schuh A. C., Schwartz L., Bernstein A., Rossant J., A requirement for Flk1 in primitive and definitive hematopoiesis and vasculogenesis. Cell 1997 89 6 981 990 2-s2.0-0030831104 (Pubitemid 27513524)
34. Baroni C. D., Vitolo D., Remotti D., Biondi A., Pezzella F., Ruco L. P., Uccini S., Immunohistochemical heterogeneity of macrophage subpopulations in human lymphoid tissues. Histopathology 1987 11 10 1029 1042 2-s2.0-0023597568 (Pubitemid 18089813)
35. Maniotis A. J., Folberg R., Hess A., Seftor E. A., Gardner L. M. G., Pe'er J., Trent J. M., Meltzer P. S., Hendrix M. J. C., Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. American Journal of Pathology 1999 155 3 739 752 2-s2.0-0032887340 (Pubitemid 29426820)
36. Ben-Baruch A., Inflammation-associated immune suppression in cancer: the roles played by cytokines, chemokines and additional mediators. Seminars in Cancer Biology 2006 16 1 38 52 2-s2.0-31344442461 10.1016/j.semcancer.2005.07. 006 (Pubitemid 43139708)
37. -/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma. Scandinavian Journal of Immunology 2010 72 6 540 547 2-s2.0-78149270433 10.1111/j.1365-3083.2010.02463.x
38. Gabrilovich D. I., Nagaraj S., Myeloid-derived suppressor cells as regulators of the immune system. Nature Reviews Immunology 2009 9 3 162 174 2-s2.0-61349100687 10.1038/nri2506
39. Serafini P., Meckel K., Kelso M., Noonan K., Califano J., Koch W., Dolcetti L., Bronte V., Borrello I., Phosphodiesterase-5 inhibition augments endogenous antitumor immunity by reducing myeloid-derived suppressor cell function. Journal of Experimental Medicine 2006 203 12 2691 2702 2-s2.0-33751531874 10.1084/jem.20061104 (Pubitemid 44833345)
40. Epstein J., Yaccoby S., Consequences of interactions between the bone marrow stroma and myeloma. The Hematology Journal 2003 4 5 310 314 2-s2.0-0141994805 10.1038/sj.thj.6200313 (Pubitemid 37259347)